Clinical Trial Update: Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of fluorouracil, leucovorin, and irinotecan (FOLFIRI) in patients with recurrent or refractory metastatic unresectabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN